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Abstract Physical activity (PA) is associated with
physiological responses thought to beneficially affect sur-
vival after breast cancer diagnosis, yet few studies have
considered the entire survivorship experience. Effects of
post-diagnosis activity on survival were examined in a
cohort of 1,423 women diagnosed with in situ or invasive
breast cancer in 1996–1997. Subjects were interviewed
soon after diagnosis and again after approximately 5 years
to assess breast cancer-related factors, including recrea-
tional PA before and after diagnosis. Date and cause of
death through 2009 were determined from the National
Death Index. Adjusted estimates were obtained using pro-
portional hazards regression and a selection model to
account for missing data. Survival was improved among
women who were highly active after diagnosis ([9.0 MET
h/week) compared to inactive women (0 MET h/week) for
all-cause [hazard ratio (HR) (95 % credible interval): 0.33
(0.22, 0.48)] and breast cancer-specific mortality [HR: 0.27
(0.15, 0.46)]. The association of PA with overall mortality
appeared stronger in the first 2 years after diagnosis [HR:
0.14 (0.03, 0.44)] compared to 2? years since diagnosis
[HR: 0.37 (0.25, 0.55)]. These findings show that post-
diagnosis PA is associated with improved survival among
women with breast cancer.
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Introduction
Greater physical activity (PA) has been linked to a
decreased risk of breast cancer [1], which is believed to
reflect its effect on circulating estrogen (ER), insulin sen-
sitivity, immune function, and adiposity [2]. As these
mechanisms may also influence breast cancer survival, PA
has gained interest as a modifiable lifestyle factor that may
improve mortality. Recent studies have examined the
relationship between PA and breast cancer survivorship,
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generally reporting reductions in mortality with greater
activity [3, 4]. However, to date, only one study has
explored the effects of post-diagnosis PA at different times
on breast cancer survival, [5] but it was limited to a Chi-
nese population with short follow-up and therefore this
issue has gone unaddressed in a U.S.-based study.
To assess the effect of PA after diagnosis on mortality
among breast cancer survivors, we analyzed data from a
large, population-based cohort of women who were diag-
nosed with a first primary breast cancer. We also consid-
ered possible heterogeneity of these effects over time since
diagnosis, hormone receptor status, and pre-diagnosis body
size.
Methods
We analyzed data from the Long Island Breast Cancer
Study Project (LIBCSP), a population-based study [6] of
newly diagnosed breast cancer cases. The objective of the
follow-up to the parent case–control study was to assess
factors associated with survival after diagnosis. Both the
parent and follow-up studies were approved by the Insti-
tutional Review Board of participating institutions.
Study population
Participants were English speaking adult women enrolled
in the parent case–control study with a first primary in situ
or invasive breast cancer diagnosed in 1996–1997 from
Nassau and Suffolk counties in New York. Incident cases
were identified through pathology departments of partici-
pating hospitals and their physicians were contacted to
confirm the diagnosis and obtain permission to contact the
patients. Of the 1,837 eligible cases, a total of 1,508
(82.1 %) agreed to participate and provided signed
informed consent. Of these, 1,414 women agreed to be
contacted at a later date for the follow-up interview, done
by mail approximately 5 years after diagnosis; informed
consent was obtained by telephone for 1,098 women. Of
the 316 who refused to participate, 60 refused at mail
contact, 65 refused at telephone contact, 18 refused due to
illness, 22 were unable to complete the interview, 55 were
lost to follow-up, and 96 were deceased with no identifiable
proxy. Of those agreeing, 1,033 subjects (68.5 % of the
original 1,508 women) completed the follow-up interview
[7], which gathered information after diagnosis.
Outcome assessment
Date and cause of death through December 31, 2009 were
established using the National Death Index (NDI) [8], a
standard source of mortality data for epidemiologic
research [9]. For the 1,508 cases from the parent study, we
constructed variables indicating death from any cause
(n = 444) and death due to breast cancer (n = 203) using
International Classification of Disease code 174.9 or
C-50.9. Cases without a death record in the NDI database
were deemed alive on December 31, 2009.
PA assessment
Recreational PA was assessed through structured inter-
views at baseline and follow-up using a modified ques-
tionnaire developed for a previous study of PA and breast
cancer [10]. The questionnaire was semi-open ended and
assessed length (start and stop dates) and duration of par-
ticipation (number of months per year) and average number
of hours per week for each activity reported; number of
months per year of each activity was converted to number
of hours per week. Where an activity was missing duration,
12 months per year was assumed for non-seasonal activi-
ties and the average number of months per year was
imputed for seasonal activities. A metabolic equivalent of
energy expenditure (MET) score was assigned to each
activity [11] with those activities that did not have a cor-
responding published MET score assigned the MET value
from a similar activity. The activity-specific MET value
was then multiplied by duration of activity in number of
hours per week, which was added across all activities for
each subject and averaged to calculate the average total
MET hours per week for each subject. From the baseline
interview, average lifetime PA was calculated (utilized as a
covariate in the analysis), while data from the follow-up
assessment were used to calculate the primary exposure:
average number of MET hours per week for each year after
diagnosis up to the time of the follow-up interview,
yielding up to 7 follow-up measures of PA.
Covariates
Questionnaires were interviewer-administered at baseline
(in person) and at follow-up (by telephone) to assess
menopausal status, education, income, treatment, and other
factors that may influence the development/prognosis of
breast cancer, including height in meters (m) and weight in
kilograms (kg) in the year before diagnosis, which were
used to calculate body mass index (BMI, weight in kg/
squared height in m). Tumor stage and ER and progester-
one receptor (PR) status were gathered from medical
records of the 1,402 women who signed a medical record
release at baseline. Treatment and tumor characteristics
were gathered from medical records for 598 of the women
who signed a medical record release at follow-up. The
treatment data from the medical record matched closely the
self-reported data (kappa coefficients: radiation therapy
736 Breast Cancer Res Treat (2014) 145:735–742
123
j = 0.97, chemotherapy j = 0.96, and hormone therapy
j = 0.92 [12]), and thus the more complete self-reported
data were used. Tumor size was obtained from the New
York State Cancer Registry.
Statistical analysis
Approximately one-third of the sample (n = 506) did not
respond to the follow-up questionnaire and were missing
information on post-diagnosis PA. There was also missing
information on start and stop dates for 10.6 % (n = 160) of
the sample, precluding matching these activities to specific
times. To account for missing data, we utilized a novel
approach which we developed previously [13]. Our pri-
mary analysis assumed that the data were missing at ran-
dom (MAR) with an ignorable missing data mechanism,
requiring models for the outcome (here, a proportional
hazards regression) and models to describe the distribution
of the missing covariates (linear and logistic regression
models, as appropriate). These latter models are ancillary
and therefore not of inferential interest; their parameters
estimates are not reported.
Post-diagnosis PA was categorized into 0 MET h/week
(referent category), 0.01–9.00 MET h/week, and [9.00
MET h/week (equivalent to approximately 108 min/week
of brisk walking at 4 miles/h or 68 min/week of jogging at
5 miles/h [14]). The cutpoint of 9 MET h/week corresponds
to that reported in similar studies [15] and therefore facil-
itates comparison of our results. This categorization also
corresponds to PA recommendations from the American
College of Sports Medicine and the American Heart
Association (moderate PA at an intensity of approximately
3.6 METs for 30 min/day, 5 days/week) [14]. For each
time point, PA was modeled as a function of age at diag-
nosis, BMI 1-year before diagnosis and the previous year’s
PA. The survival models included categorized PA in the
previous period, and were adjusted for age, chemotherapy
treatment, pre-diagnosis BMI (C25 vs. \25 kg/m2), and
tumor size, which have been shown to be related to both
breast cancer survival and post-diagnosis PA levels [16,
17]. The inclusion of chemotherapy treatment in the PA
model and other treatment variables (radiation therapy and
hormone therapy) in the survival model did not change the
parameter estimates (data not shown). Due to the com-
plexity of the statistical models parsimony was a major
consideration, and therefore these variables were omitted
from the respective models in the final analysis. In addition
to the overall association of PA with mortality, we con-
ducted analyses stratified by time since diagnosis (before
and after 2 years since diagnosis), ER/PR status (ER? and
PR? vs. ER- or PR-), and BMI prior to diagnosis.
Missing data on chemotherapy (32.2 %), tumor size
(31.6 %), and ER/PR status (34 %) were accounted for
using logistic regression models for each as functions of
age, and for chemotherapy and tumor size, income and
education. Minimal amounts of missing data were noted for
baseline PA (0.93 %), menopausal status (1.99 %), pre-
diagnosis BMI (1.13 %), adult weight change (from age 20
to 1 year before diagnosis; 1.66 %), education (0.40 %),
and income (0.27 %). These small amounts were unlikely
to influence our results, and the additional cost of
accounting for this exceeded the potential benefit, thus we
excluded subjects missing these data. Our analysis thus
included 1,423 women (94.4 % of the original 1,508
cases), with 420 total deaths, 195 due to breast cancer.
To evaluate sensitivity to the missing data assumptions,
we fit two additional models for the main effects based on
the one described above. The first assumes a non-ignorable
missing data mechanism (labeled Model 2 in results),
which included a logistic regression model for the proba-
bility of PA data being observed as a function of age and
previous PA, which accounts for the potential for the data
to be not missing at random (NMAR)—that the probability
that PA is observed or not is related to its potentially
unobserved value [13, 18]. This method can account for the
potential influence of selection bias, where the sample we
have full observation on may not be representative of the
source population. Finally, we conducted a complete case
analysis (Model 3 in results) where we assumed that the
data constituted a random sample from the larger popula-
tion, or that PA is missing completely at random (MCAR)
[13, 18]. This model included 946 subjects (217 deaths
from any cause; 101 breast cancer deaths) with non-miss-
ing assessments for PA, but accounts for missing data in
the chemotherapy and tumor size variables.
These models (models 1–3 and the stratified models
described above) were estimated within a Fully Bayesian
framework, with vague prior distributions on the model
parameters as described in our earlier work [13], yielding
effect estimates equivalent to a standard frequentist ana-
lysis. Samples from the posterior distribution of the
regression parameters (log-hazard ratios) were obtained
with WinBUGS 1.4 [19], which was run for 100,000 iter-
ations, discarding the first 50,000 as a burn-in sample,
retaining every 5th iteration to reduce serial correlation.
Posterior hazard ratios (HR) and corresponding 95 %
credible intervals (CrI) were calculated by the anti-loga-
rithm of the mean and the 2.5th and 97.5th percentiles of
these samples, respectively.
Results
Median survival time among women in our study was
12.7 years with times ranging from 0.23 to 13.42 years. At
diagnosis, most women were postmenopausal, and ages
Breast Cancer Res Treat (2014) 145:735–742 737
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ranged from 25 to 91 years (Table 1). Less than half
reported receiving chemotherapy treatment, while the
majority received radiation therapy or hormone therapy.
In Model 1 (Table 2), which assumes post-diagnosis PA
is MAR, we note a substantial decrease in risk of death
from any cause [HR (95 % CrI): 0.33 (0.22, 0.48)] and
from breast cancer [HR: 0.27 (0.15, 0.46)] for the highest
level of PA ([9.0 Met h/week) compared to inactive
women. A somewhat smaller effect estimate was noted for
women with more moderate activity levels for all-cause
mortality [HR: 0.43 (0.20, 0.84)], but we saw similar
associations across activity levels for breast cancer-specific
mortality. This pattern was similar for Model 2 which
considers the potential for the data to be NMAR; thus, it
appears that the original findings are robust with regard to
this assumption. The hazards ratios for the associations
from Model 3, which do not account for missing data and
are based on a complete case analysis only, are more
pronounced, especially for breast cancer-related deaths;
thus, a portion of these effects could be due to the pattern
of missing data.
For all-cause mortality, the inverse association with the
highest level of PA appeared stronger during the first 2
years following diagnosis than later years, although an
inverse association was noted during both periods
(Table 3). The association of PA with mortality was more
pronounced among women with tumors that were ER? and
PR? compared to either negative. Of particular note: the
CrI for moderate activity levels included one for ER-/
PR- women, while an inverse effect at this activity level
was most evident for women in the ER?/PR? group.
Finally, a stronger association of PA with all-cause mor-
tality was also noted for women who were not overweight
before diagnosis compared to those who were and a similar
association was noted for breast cancer-specific mortality.
Discussion
In our analysis, greater levels of recreational PA under-
taken after diagnosis were associated with substantially
lower risk of death from any cause as well as death due to
breast cancer in a large, population-based cohort of women
who were diagnosed with a first primary breast cancer in
1996–1997. The beneficial effect of PA appeared slightly
stronger in the time period following diagnosis, and also
among women who were not overweight in the year before
diagnosis for both all-cause and breast cancer-specific
mortality. These findings also suggest that the effect may
be stronger among women with hormone-dependent
tumors, and a trend was noted for moderate activity to be
somewhat more protective in this group. Nevertheless, the
risk of death was substantially reduced among women who
Table 1 Characteristics of 1,423 women diagnosed with a first pri-
mary breast cancer in 1996–1997 on Long Island, NY, with follow-up
assessments in 2002–2004
N (%)
Deaths as of December 31, 2009
All-cause 420 (29.5)
Breast cancer specific 195 (13.7)
PA before diagnosisa
0 MET h/week 582 (40.9)
0.1–9.0 MET h/week 355 (25.0)
[9 MET h/week 486 (34.1)
PA 1 year after diagnosisa
0 MET h/week 213 (27.1)
0.1–9.0 MET h/week 94 (11.9)
[9 MET h/week 480 (61.0)
Missing 619
PA 2 years after diagnosisa
0 MET h/week 193 (25.1)
0.1–9.0 MET h/week 96 (12.5)
[9 MET h/week 480 (62.4)
Missing 602
PA 3 years after diagnosisa
0 MET h/week 183 (23.8)
0.1–9.0 MET h/week 96 (12.5)
[9 MET h/week 490 (63.7)
Missing 560
PA 4 years after diagnosisa
0 MET h/week 177 (23.2)
0.1–9.0 MET h/week 89 (11.7)
[9 MET h/week 496 (65.1)
Missing 542
PA 5 years after diagnosisa
0 MET h/week 183 (24.7)
0.1–9.0 MET h/week 83 (11.2)
[9 MET h/week 474 (64.0)
Missing 524
PA 6 years after diagnosisa
0 MET h/week 349 (62.3)
0.1–9.0 MET h/week 30 (5.4)
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were physically active after diagnosis in all subgroups that
we examined.
PA is associated with several metabolic consequences
that may favor survival from breast cancer [20], which was
the most common cause of death in our study. A potential
mechanism for these effects is through the increase in
insulin sensitivity and reduced endogenous ER production
mediated by a reduction in adipose tissue [21–23], but it
could also be due to PA’s independent increase in the
amount of sex hormone-binding globulin (SHBG) and
improvement in insulin sensitivity [24]. While hormonal
pathways offer the most convincing explanations, PA may
also improve the immune response [25], possibly by pro-
moting killer-cell, macrophage, and cytokine activity [26,
27] as well as upregulating antioxidant enzyme activity
[28], which may protect against DNA damage.
Our group has recently reported an inverse association
between recreational PA before diagnosis and mortality in
this cohort [29], however, our findings here indicate that the
effect of PA after diagnosis is stronger. Two recent reviews
have focused on the relationship between PA and breast
cancer survival [3, 4], with both concluding a fairly con-
sistent inverse association between PA and breast cancer
survival, with Patterson and colleagues noting an average
reduction in relative risk of death of 30 % [4], similar in
magnitude to a more recent analysis, [30] which is not as
strong as the effect we report here. However, a report by
Irwin et al. [15] observed a very strong risk reduction of
being physically active 2 years after diagnosis; for women
who expended 9 or more MET h/week compared to those
who were inactive, mortality was reduced by two-thirds
(all-cause mortality HR: 0.33, 95 % CI: 0.15–0.73), which
is similar to the magnitude of effect we observed.
While our findings are in general agreement with pre-
vious studies, our more pronounced associations are likely
due to differences in study design. Our study followed
women forward from diagnosis, while previous analyses
included women who were well into their survivorship
experience, usually 2–3 years post-diagnosis but as much
as 4 years in one study [31], and over 10 years in another
[32, 33]. Excluding women who do not survive past the
first several years could induce length-biased sampling [34]
and are thus not generally representative of all breast
cancer survivors. Additionally, our PA assessment allowed
us to obtain longitudinal measures over the entire follow-
up period, while most previous studies utilized data from
single time periods, which included pre-diagnosis and post-
diagnosis activity [3, 4]. Timing of assessment is impor-
tant, as previous research has suggested that among breast
cancer survivors, PA levels decline during the first year,














\2 cm 442 (80.5)
C2 cm 107 (19.5)
Missing 874
BMI 1 year before diagnosis
\18.5 kg/m2 25 (1.8)
18.5–24.9 kg/m2 633 (44.5)
25.0–29.9 kg/m2 451 (31.7)
C30.0 kg/m2 314 (22.1)
Weight change from age 20 to 1 year before diagnosis
\3 kg gain or any loss 238 (16.7)
[3 kg gain 1,185 (83.3)












High school or less 683 (48.0)
Some college 339 (23.8)
College graduate 185 (13.0)






a Average MET hours per week for recreational PA over relevant
interval. Note that the total number of subjects available for each
assessment declines over time as subjects leave the cohort due to
death or censoring
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return to their pre-diagnosis activity levels by 3 years [17].
Failing to fully capture the return to higher levels of PA
among those who survive longer could partly explain the
differences in reported associations. Only one other study
to our knowledge utilized data on breast cancer survivors
both near diagnosis until several years after [5], but this
analysis was limited to women living in China. Their
results indicate a stronger inverse association for activity
undertaken several years after diagnosis, which is different
from what we observed. Their findings with regard to ER/
PR status were also not consistent with ours. However, our
finding of a stronger inverse relationship among women
with ER?/PR? tumors is highly plausible since it is con-
sistent with other observations that PA is associated with
reduced steroid hormone levels among postmenopausal
women, [35] who make up the majority of this cohort.
Strengths of our study include its larger size and popu-
lation-based design that included breast cancer survivors
from the time of diagnosis. Additionally, we were able to
ascertain PA over several years allowing us to evaluate the
associations of activity near or after diagnosis. We also
employed a rigorous approach to deal with missing data,
which is far superior to the ad hoc methods often employed
in epidemiologic analyses [18]. Our comparisons of Model
3 with Model 1 illustrate the potential for bias in analyses
that do not properly control for missing data. Our sensi-
tivity analysis further illustrated the robustness of our main
model (Model 1) with regard to assuming a potentially
more problematic selection bias scenario (Model 2). These
findings emphasize the potential for improper treatment of
missing data to lead to erroneous conclusions [18]. While
selection models like we used can be powerful tools when
faced with missing data they do rely on untestable
assumptions [36], and so sensitivity analyses, such as the
one we employed, are important.
Possible limitations of our study include the use of self-
reported PA [37], however, the comprehensive instrument we
used was developed specifically for the study of PA and breast
cancer [10] and has been successfully used in other studies
[38, 39]. The use of proxy interviews is also a potential source
of bias for PA data [40], however, the number of these was
small (\8 %). Additionally, a previous report suggests that
including data from proxy interviews of PA data does not
necessarily result in bias [41]. The strong inverse associations
noted could be due to healthier women being more physically
active while those who were sicker were more inclined to be
less active. However, this is unlikely to entirely explain the
effects as we adjusted for markers of severity, tumor charac-
teristics, and treatment. The results were also robust when
considering PA later in the survivorship experience, when
effects would likely be attenuated. Power for interactions was
limited, in particular for death due to breast cancer, therefore,
we did not conduct more comprehensive stratified analyses.
Finally, the women in our study population were predomi-
nately white, and therefore these results may not be applicable
to the broader population of all breast cancer survivors.
Table 2 Posterior HRs (and 95 % CrIs) for the association between all-cause and breast cancer-specific mortality and post-diagnosis PA levels
(MET h/week) assessed yearly over entire follow-up, among 1,423 women diagnosed with a first primary breast cancer in 1996–1997 on Long
Island, NY, and followed through December 31, 2009
Post-diagnosis PA (MET h/week) HRa (95 % CrI)
All-cause mortality (420 deaths)
Model 1b Model 2c Model 3d
0 1.0 1.0 1.0
0.1–9.0 0.43 (0.20, 0.84) 0.43 (0.20, 0.83) 0.30 (0.12, 0.63)
[9.0 0.33 (0.22, 0.48) 0.32 (0.23, 0.47) 0.27 (0.16, 0.42)
Post-diagnosis PA (MET h/week) Breast cancer-specific mortality (195 deaths)
Model 1b Model 2c Model 3d
0 1.0 1.0 1.0
0.1–9.0 0.24 (0.07, 0.65) 0.25 (0.07, 0.65) 0.11 (0.02, 0.41)
[9.0 0.27 (0.15, 0.46) 0.26 (0.15, 0.44) 0.18 (0.08, 0.36)
a All proportional hazards models adjusted for age, pre-diagnosis BMI, chemotherapy treatment, and tumor size
b Model 1 includes models for covariates with missing data: PA, chemotherapy, and tumor size, which assumes that the missing data mechanism
for PA is ignorable
c Model 2 follows specification of Model 1, but additionally includes model for the probability of missing PA data as a function of the missing
PA variable (assumes PA is NMAR)
d Model 3 includes model for time to death among subjects with complete data on PA (n = 946), but accounts for missing chemotherapy and
tumor size, which assumes that PA data is MCAR
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In summary, our results indicate that PA after breast
cancer diagnosis is associated with better survival. We noted
that the beneficial effect of PA may vary somewhat over
time, by hormone receptor status, as well as by body size just
before diagnosis, however, a reduction in mortality was
consistently seen in all stratified analyses. Future research
should consider PA over the entire survivorship experience
in order to identify the most relevant time for interventions.
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